本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

0.3763
+0.02597.39%
盤後0.3761-0.0002-0.05%19:30 EDT
成交量:12.85萬
成交額:4.73萬
市值:1,421.14萬
市盈率:-0.86
高:0.3900
開:0.3630
低:0.3512
收:0.3504
52周最高:1.98
52周最低:0.2500
股本:3,776.61萬
流通股本:2,584.64萬
量比:0.24
換手率:0.50%
股息:- -
股息率:- -
每股收益(TTM):-0.4366
每股收益(LYR):-0.4366
淨資產收益率:-2174.98%
總資產收益率:-247.30%
市淨率:-9.11
市盈率(LYR):-0.86

資料載入中...

2026/03/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/11/25

SEC問詢函

Form CORRESP - Correspondence
2025/08/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/13

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC問詢函

Form CORRESP - Correspondence
2024/05/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/09/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC問詢函

Form CORRESP - Correspondence
2023/08/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]